News
2h
Health and Me on MSNWeight Loss Drugs For Dementia – Study Finds It May Prevent Cognitive As Well As Cardiovascular IssuesAs the popularity of the type-2 diabetes drugs have risen, researcher have been looking into different aspects of it to ...
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
New research reveals GLP-1 drugs like Ozempic may reduce stroke risk and improve recovery. At the 22nd Annual Meeting of the ...
GLP-1 RAs are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin.
A tiny flower-shaped particle could help to pave the way for a new treatment approach to Alzheimer's and Parkinson's that targets the root causes.
WEIGHT loss jabs could help control asthma symptoms in obese people, a study suggests – and it’s not just about losing weight ...
The disorder commonly affects mobility, causing shaking and stiffness as well as hindering balance and coordination. There is ...
GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...
Common medicines, including diabetes, cancer, and antiviral drugs, may offer new hope in slowing dementia. UK researchers, including a team from the University of Cambridge, have uncovered strong ...
4don MSN
GLP-1s - which mimic the effects of the hormone that stimulates insulin release, suppressing glucagon, and slowing gastric ...
FAT jabs are better than widely prescribed metformin when it comes to curbing dementia risk in people with type 2 diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results